Patients who develop acute kidney injury (AKI) after transcatheter aortic valve replacement (TAVR) show an increased mortality rate at one year post-procedure, according to late-breaking trial results presented at Cardiovascular Research Technologies (CRT) 2020 in National Harbor, Maryland.